GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » Cyclically Adjusted Revenue per Share

Gerresheimer AG (XTER:GXI) Cyclically Adjusted Revenue per Share : €54.56 (As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Gerresheimer AG's adjusted revenue per share for the three months ended in Feb. 2024 was €13.496. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €54.56 for the trailing ten years ended in Feb. 2024.

During the past 12 months, Gerresheimer AG's average Cyclically Adjusted Revenue Growth Rate was 4.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Gerresheimer AG was 7.50% per year. The lowest was 3.80% per year. And the median was 6.30% per year.

As of today (2024-06-14), Gerresheimer AG's current stock price is €103.70. Gerresheimer AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Feb. 2024 was €54.56. Gerresheimer AG's Cyclically Adjusted PS Ratio of today is 1.90.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Gerresheimer AG was 2.29. The lowest was 0.95. And the median was 1.69.


Gerresheimer AG Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Gerresheimer AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG Cyclically Adjusted Revenue per Share Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.83 43.52 46.46 51.46 54.05

Gerresheimer AG Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.42 53.24 53.86 54.05 54.56

Competitive Comparison of Gerresheimer AG's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's Cyclically Adjusted PS Ratio falls into.



Gerresheimer AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Gerresheimer AG's adjusted Revenue per Share data for the three months ended in Feb. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=13.496/124.5109*124.5109
=13.496

Current CPI (Feb. 2024) = 124.5109.

Gerresheimer AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201405 10.611 99.263 13.310
201408 10.324 99.823 12.877
201411 10.586 99.543 13.241
201502 9.585 99.217 12.029
201505 11.429 100.417 14.171
201508 10.959 100.617 13.562
201511 8.878 99.717 11.085
201602 10.248 99.317 12.848
201605 11.114 100.617 13.753
201608 11.211 101.017 13.818
201611 11.364 100.517 14.077
201702 9.644 101.217 11.863
201705 10.813 101.817 13.223
201708 10.556 102.617 12.808
201711 11.925 102.117 14.540
201802 9.247 102.317 11.253
201805 10.633 103.917 12.740
201808 11.325 104.517 13.491
201811 12.512 104.217 14.948
201902 9.826 103.817 11.785
201905 11.331 105.418 13.383
201908 11.420 106.018 13.412
201911 11.739 105.318 13.878
202002 9.677 105.618 11.408
202005 11.519 106.018 13.528
202008 11.120 106.018 13.060
202011 12.829 105.018 15.210
202102 9.645 107.018 11.222
202105 12.006 108.170 13.820
202108 12.183 109.118 13.902
202111 13.845 110.173 15.647
202202 11.809 111.754 13.157
202205 14.160 115.760 15.230
202208 15.050 116.709 16.056
202211 16.838 119.872 17.490
202302 14.437 121.454 14.800
202305 15.217 122.824 15.426
202308 14.127 123.878 14.199
202311 15.786 123.668 15.894
202402 13.496 124.511 13.496

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Gerresheimer AG  (XTER:GXI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Gerresheimer AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=103.70/54.56
=1.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Gerresheimer AG was 2.29. The lowest was 0.95. And the median was 1.69.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Gerresheimer AG Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG (XTER:GXI) Business Description

Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Executives
Dietmar Siemssen Board of Directors
Dr. Lukas Burkhardt Board of Directors
Andrea Abt Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines